Effects of Imipramine on Individuals Varying in Level of Depression
Abstract
In the belief that studies with normal subjects are relevant to the assessment of psychotropic drugs for clinical use, the authors examined the antidepressant and anti-anxiety effects of imipramine in a group of nonhospitalized, asymptomatic subjects selected to differ in level of (nonclinical) depression. Although some of the results might be termed paradoxical, it was demonstrated that the antidepressant property of the drug, for which it is clinically utilized, is also evident in normal subjects.
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.- Personal login
- Institutional Login
- Sign in via OpenAthens
- Register for access
-
Please login/register if you wish to pair your device and check access availability.
Not a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).
